Skip to content
healthcare.dev

Fludeoxyglucose F 18

NDC 76318-334, Fludeoxyglucose F-18, injection, solution, from Massachusetts General Hospital.

Product NDC
76318-334
Status
Listed
Labeler
Massachusetts General Hospital
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204333
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76318-334 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FLUDEOXYGLUCOSE F-18300 mCi/mL

Pharmacologic classes

Radioactive Diagnostic Agent [EPC]; Radiopharmaceutical Activity [MoA]

Package NDCNDC-11Package
76318-334-507631803345050 mL in 1 VIAL (76318-334-50)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/232fbb91-402e-44d8-a0cf-6813980b8ead

Use it

Look up 76318-334 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76318-334 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76318-334. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.